All treatments
Treatment
Inrebic 100 mg hard capsules clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
Phase II Study of Fedratinib and Nivolumab Combination in Patients with Myelofibrosis and Resistance or Suboptimal Response to JAK-inhibitor Treatment - The FRACTION Trial
This study looks at combining two medicines, fedratinib and nivolumab, for people with myelofibrosis whose current JAK-inhibitor treatment isn't working well. We want to see how well this new combination reduces symptoms and if people need fewer blood transfusions.
For: Primary and secondary MyelofibrosisGermany - Ongoing, recruitingPhase I and Phase II (Integrated)- Other
Fedratinib in Combination with CC-486, a Hypomethylating Agent, in Patients with Accelerated Phase Myelofibrosis - FAMy
This study, called FAMy, is looking at a new combination of two medicines, Inrebic and Onureg, for people with a specific type of bone marrow disorder called accelerated phase myelofibrosis. It aims to find the safest and most effective dose of this new treatment.
For: Myeloproliferative neoplasm in accelerated phase (MPN-AP)Germany